Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O9DH
|
|||
Former ID |
DNC001073
|
|||
Drug Name |
Oximidine I
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C24H28N2O7
|
|||
Canonical SMILES |
CC=CC1C(O1)C(C(CC=CNC(=O)C=CC=NOC)OC(=O)C2=C(C=CC=C2O)C=C)O
|
|||
InChI |
1S/C24H28N2O7/c1-4-9-19-23(32-19)22(29)18(12-7-14-25-20(28)13-8-15-26-31-3)33-24(30)21-16(5-2)10-6-11-17(21)27/h4-11,13-15,18-19,22-23,27,29H,2,12H2,1,3H3,(H,25,28)/b9-4-,13-8-,14-7-,26-15+
|
|||
InChIKey |
HFJXCVFNVNHCKF-XTLNGFDXSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Vacuolar-type proton ATPase (v-ATPase) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases. J Pharmacol Exp Ther. 2001 Apr;297(1):114-20. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.